Back to Journals » Lung Cancer: Targets and Therapy » Volume 6

Lung Cancer: Targets and Therapy


Archive: Volume 6, 2015

Epiregulin as a therapeutic target in non-small-cell lung cancer

Sunaga N, Kaira K

Lung Cancer: Targets and Therapy 2015, 6:91-98

Published Date: 12 October 2015

Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small- cell lung cancer: a retrospective study

Minami S, Ogata Y, Yamamoto S, Komuta K

Lung Cancer: Targets and Therapy 2015, 6:83-90

Published Date: 25 September 2015

First-line treatment of advanced ALK-positive non-small-cell lung cancer

Gandhi S, Chen H, Zhao Y, Dy GK

Lung Cancer: Targets and Therapy 2015, 6:71-82

Published Date: 18 September 2015

Targeting PD-1/PD-L1 in lung cancer: current perspectives

González-Cao M, Karachaliou N, Viteri S, Morales-Espinosa D, Teixidó C, Sánchez Ruiz J, Molina-Vila MÁ, Santarpia M, Rosell R

Lung Cancer: Targets and Therapy 2015, 6:55-70

Published Date: 31 July 2015

Non-small-cell lung carcinoma: role of the Notch signaling pathway

Barse L, Bocchetta M

Lung Cancer: Targets and Therapy 2015, 6:43-53

Published Date: 26 June 2015

AXL receptor tyrosine kinase as a therapeutic target in NSCLC

Okimoto RA, Bivona TG

Lung Cancer: Targets and Therapy 2015, 6:27-34

Published Date: 30 April 2015

Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy

Yu BF, Lu YF, Gao F, Jing P, Han W, Zhang PC, Liu GL, Ru N, Cui GH, Xu XH, Sun CL, Guan CJ, Che YB, Wu YL, Ma ZL, Fu Q, Liu J, Wang HY

Lung Cancer: Targets and Therapy 2015, 6:1-11

Published Date: 7 January 2015